Literature DB >> 21264498

Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat.

Sreeja Purushothaman1, R Renuka Nair, V S Harikrishnan, A C Fernandez.   

Abstract

Left ventricular hypertrophy is an adaptive response to hypertension, and an independent clinical risk factor for cardiac failure, sudden death, and myocardial infarction. As regression of cardiac hypertrophy is associated with a lower likelihood of cardiovascular events, it is recognized as a target of antihypertensive therapy. This necessitates identification of factors associated with the initiation and progression of hypertrophy. Oxidative stress and metabolic shift are intimately linked with myocardial hypertrophy, but their interrelationship is not clearly understood. This study proposes to identify the temporal sequence of events so as to distinguish whether oxidative stress and metabolic shift are a cause or consequence of hypertrophy. Spontaneously hypertensive rat (SHR) was used as the experimental model. Cardiac hypertrophy was apparent at 2 months of age, as assessed by hypertrophy index and brain natriuretic peptide gene expression. Enhanced myocardial lipid peroxidation accompanied by nuclear factor-kappa B gene expression in one-month-old SHR suggests that oxidative stress precedes the development of hypertrophy. Metabolic shift identified by reduction in the expression of peroxisome proliferator-activated receptor-alpha, medium chain acyl CoA dehydrogenase, and carnitine palmitoyltransferase 1β was seen at 4 months of age, implying that reduction of fatty acid oxidation is a consequence of hypertrophy. Information on the temporal sequence of events associated with hypertrophy will help in the prevention and reversal of cardiac remodeling. Investigations aimed at prevention of hypertrophy should address reduction of oxidative stress. Both, oxidative stress and metabolic modulation have to be considered for studies that focus on the regression of hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21264498     DOI: 10.1007/s11010-011-0711-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes.

Authors:  Q M Chen; V C Tu; Y Wu; J J Bahl
Journal:  Arch Biochem Biophys       Date:  2000-01-01       Impact factor: 4.013

3.  Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation.

Authors:  W G Niehaus; B Samuelsson
Journal:  Eur J Biochem       Date:  1968-10-17

4.  Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1.

Authors:  Tao Hang; Zhaoqi Huang; Shisen Jiang; Jianbin Gong; Chunhui Wang; Dujiang Xie; Hailing Ren
Journal:  Ann Clin Lab Sci       Date:  2006       Impact factor: 1.256

5.  A positive association between cardiomyocyte volume and serum malondialdehyde levels.

Authors:  Indira K Adiga; R Renuka Nair
Journal:  Int J Cardiol       Date:  2007-02-07       Impact factor: 4.164

6.  Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.

Authors:  Sudhiranjan Gupta; David Young; Subha Sen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-04       Impact factor: 4.733

7.  Myocardial hypertrophy of normotensive Wistar-Kyoto rats.

Authors:  Ernesto A Aiello; María C Villa-Abrille; Eduardo M Escudero; Enrique L Portiansky; Néstor G Pérez; María C Camilión de Hurtado; Horacio E Cingolani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-11-20       Impact factor: 4.733

8.  Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats.

Authors:  E Véricel; M Narce; L Ulmann; J P Poisson; M Lagarde
Journal:  Mol Cell Biochem       Date:  1994-03-16       Impact factor: 3.396

9.  Peroxisome proliferator-activated receptor alpha is downregulated in the failing human heart.

Authors:  Joanna Karbowska; Zdzisław Kochan; Ryszard T Smoleński
Journal:  Cell Mol Biol Lett       Date:  2003       Impact factor: 5.787

10.  Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat.

Authors:  M E Christe; R L Rodgers
Journal:  J Mol Cell Cardiol       Date:  1994-10       Impact factor: 5.000

View more
  12 in total

1.  Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.

Authors:  Saifudeen Ismael; Sreeja Purushothaman; V S Harikrishnan; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2015-05-15       Impact factor: 3.396

2.  Reduction of rat cardiac hypertrophy by osthol is related to regulation of cardiac oxidative stress and lipid metabolism.

Authors:  Feng Zhou; Wen Zhong; Jie Xue; Zhen-lun Gu; Mei-lin Xie
Journal:  Lipids       Date:  2012-08-24       Impact factor: 1.880

3.  Mitoprotective antioxidant EUK-134 stimulates fatty acid oxidation and prevents hypertrophy in H9C2 cells.

Authors:  Sreeja Purushothaman; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2016-08-11       Impact factor: 3.396

4.  Changes in short-chain acyl-coA dehydrogenase during rat cardiac development and stress.

Authors:  Jinxian Huang; Lipeng Xu; Qiuju Huang; Jiani Luo; Peiqing Liu; Shaorui Chen; Xi Yuan; Yao Lu; Ping Wang; Sigui Zhou
Journal:  J Cell Mol Med       Date:  2015-03-08       Impact factor: 5.310

Review 5.  Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol.

Authors:  Shereen M Hamza; Jason R B Dyck
Journal:  Front Physiol       Date:  2014-08-05       Impact factor: 4.566

6.  Accelerated decline in cardiac stem cell efficiency in Spontaneously hypertensive rat compared to normotensive Wistar rat.

Authors:  Sherin Saheera; Renuka R Nair
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

7.  Histamine-2 receptor antagonist famotidine modulates cardiac stem cell characteristics in hypertensive heart disease.

Authors:  Sherin Saheera; Ajay G Potnuri; Renuka Nair
Journal:  PeerJ       Date:  2017-10-09       Impact factor: 2.984

8.  Systemic leukotriene B4 receptor antagonism lowers arterial blood pressure and improves autonomic function in the spontaneously hypertensive rat.

Authors:  Paul J Marvar; Emma B Hendy; Thomas D Cruise; Dawid Walas; Danielle DeCicco; Rajanikanth Vadigepalli; James S Schwaber; Hidefumi Waki; David Murphy; Julian F R Paton
Journal:  J Physiol       Date:  2016-07-08       Impact factor: 5.182

9.  Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and -γ in spontaneous hypertensive rats.

Authors:  Yanru Sun; Mingfeng Han; Zhenhuang Shen; Haibo Huang; Xiaoqing Miao
Journal:  Saudi J Biol Sci       Date:  2017-10-10       Impact factor: 4.219

10.  Dronedarone produces early regression of myocardial remodelling in structural heart disease.

Authors:  Begoña Quintana-Villamandos; Jose Juan Gomez de Diego; María Jesús Delgado-Martos; David Muñoz-Valverde; María Luisa Soto-Montenegro; Manuel Desco; Emilio Delgado-Baeza
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.